Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/3/24 18:24 | 4/3/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 5 | S.dm | -3,523 | 8.89 | 0 | -396 | 1,109 | M | |||||||||||||||
5/2/24 17:41 | 4/30/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 6 | S | -985 | 10.42 | 0 | -95 | 7,293 | D | ||||||||||||||||
4/29/24 18:41 | 2/22/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | M.d | 248 | 6.53 | 0 | 38 | 6 | 640 | D | ||||||||||||||
4/29/24 18:41 | 2/22/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | S.d | -248 | 6.53 | 0 | -38 | 640 | D | |||||||||||||||
4/18/24 17:12 | 4/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 4 | M.dm | 1,237 | 4.99 | 0 | 248 | 25 | 1,231 | D | ||||||||||||||
4/18/24 17:12 | 4/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 4 | S.dm | -1,237 | 4.99 | 0 | -248 | 1,231 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |